Genetic control of NKT cell numbers maps to major diabetes and lupus loci

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 2873-2878

  Esteban, Luis M ^d   Tsoutsman, Tatiana ^d   Jordan, Margaret A ^e   Roach, Daniel ^d   Poulton, Lynn D ^d   Brooks, Andrew ^f   Naidenko, Olga V ^a   Sidobre, Stephane ^b   Godfrey, Dale I ^c   Baxter, Alan G ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^d CENTENARY INSTITUTE   (Australia)

^e JAMES COOK UNIVERSITY   (Australia)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BACKCROSSING; CHROMOSOME 1; CHROMOSOME 2; DNA POLYMORPHISM; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE LOCUS; GENETIC LINKAGE; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOME; IMMUNE SYSTEM; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LINKAGE ANALYSIS; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOCYTE;

EID: 0042333462     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.2873     Document Type: Article

References (63)

1. Sumida, T., A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi. 1995. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1163.
2. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035.
3. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46:572.
4. - thymocytes. J. Autoimmun. 10:279.
5. Wilson, S. B., S. C. Kent, K. T. Patton. T. Orban, R. A. Jackson, M. Exley, S. Porcelli, D. A. Schatz, M. A. Atkinson, S. P. Balk, et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes. [Published erratum appears in 1999 Nature 399:84.] Nature 391:177.
6. Illes, Z., T. Kondo, J. Newcombe, N. Oka, T. Tabira, and T. Yamamura. 2000. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164:4375.
7. Oishi, Y., T. Sumida. A. Sakamoto, Y. Kita, K. Kurasawa, Y. Nawata, K. Takabayashi, H. Takahashi, S. Yoshida, M. Taniguchi, et al. 2001. Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 28:275.
8. -Vα 24JαQ T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis. Clin. Immunol. 98:11.
9. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or 1L-10. J. Exp. Med. 187:1047.
10. - Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831.
11. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531.
12. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer. J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
13. Jahng, A. W., I. Maricic, B. Pedersen, N. Burdin, O. Naidenko, M. Kronenberg, Y. Koezuka, and V. Kumar. 2001. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyetitis. J. Exp. Med. 194:1789.
14. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801.
15. Mars, L. T., V. Laloux. K. Goude, S. Desbois, A. Saoudi, L. Van Kaer, H. Lassmann, A. Herbelin, A. Lehuen, and R. S. Liblau. 2002. Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 168:6007.
16. + deficiency in the nonobese diabetic mouse. Mamm. Genome 12:175.
17. Poulton, L. D., M. J. Smyth, C. G. Hawke, P. Silveira, D. Shepherd, O. V. Naidenko, D. I. Godfrey, and A. G. Baxter. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13:887.
18. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi. C.-R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1 tetramers. J. Exp. Med. 192:741.
19. Dietrich, W. F., J. Miller, R. Steen, M. A. Merchant, D. Damron-Boles, Z. Husain, R. Dredge, M. J. Daly, K. A. Ingalls, J. T. O'Connor, et al. 1996. A comprehensive genetic map of the mouse genome. Nature 380:149.
20. Jordan, M. A., P. A. Silveira, D. P. Shepherd, C. Chu, S. J. Kinder, J. Chen, L. J. Palmisano, L. D. Poulton, and A. G. Baxter. 2000. Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J. Immunol. 165:1673.
21. Silveira, P. A., A. G. Baxter, W. E. Cain, and I. R. van Driel. 1999. A major linkage region on distal chromosome 4 confers susceptibility to mouse autoimmune gastritis. J. Immunol. 162:5106.
22. Lander, E. S., P. Green, J. Abrahamson, A. Barlow, M. J. Daly, S. E. Lincoln, and L. Newburg. 1987. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1:174.
23. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241.
24. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29:1.
25. Baxter, A. G., and A. Cooke. 1995. The genetics of the NOD mouse. Diabetes Metab. Rev. 11:315.
26. McAleer, M. A., P. Reifsnyder, S. M. Palmer, M. Prochazka, J. M. Love, J. B. Copeman, E. E. Powell, N. R. Rodrigues, J. B. Prins. D. V. Serreze, et al. 1995. Crosses of NOD mice with the related NON strain: a polygenic model for IDDM. Diabetes 44:1186.
27. Podolin, P. L., P. Denny, C. J. Lord, N. J. Hill, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 1997. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgrl. J. Immunol. 159:1835.
28. Podolin, P. L., P. Denny, N. Armitage, C. J. Lord, N. J. Hill, E. R. Levy, L. B. Peterson, J. A. Todd, L. S. Wicker, and P. A. Lyons. 1998. Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3. Mamm. Genome 9:283.
29. 2-microglobulin. J. Immunol. 160:1472.
30. Kanagawa, O., G. Xu, A. Tevaarwerk, and B. A. Vaupel. 2000. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-γ receptor loci. J. Immunol. 164:3919.
31. Brodnicki, T. C., P. McClive, S. Couper, and G. Morahan. 2000. Localization of Idd1 I using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene. Immunogenetics 51:37.
32. Lyons, P. A., N. Armitage, F. Argentina, P. Denny, N. C. Hill, C. J. Lord, M. B. Wilusz, L. B. Peterson, L. S. Wicker, and J. A. Todd. 2000. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 10:446.
33. Fox, C. J., A. D. Paterson, S. M. Mortin-Toth, and J. S. Danska. 2000. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am. J. Hum. Genet. 67:67.
34. Lyons, P. A., W. W. Hancock, P. Denny, C. J. Lord. N. J. Hill, N. Armitage, T. Siegmund, J. A. Todd, M. S. Phillips, J. F. Hess, et al. 2000. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 13:107.
35. Hill, N. J., P. A. Lyons, N. Armitage, J. A. Todd. L. S. Wicker, and L. B. Peterson. 2000. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMPI loci in humans. Diabetes 49:1744.
36. Lyons, P. A., N. Armitage, C. J. Lord, M. S. Phillips, J. A. Todd, L. B. Peterson, and L. S. Wicker. 2001. Mapping by genetic interaction: high-resolution congenic mapping of the type I diabetes loci Idd 10 and Idd 18 in the NOD mouse. Diabetes 50:2633.
37. Rogner, U. C., C. Boitard, J. Morin, E. Melanitou, and P. Avner. 2001. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. Genomics 74:163.
38. Lamhamedi-Cherradi, S. E., O. Boulard, C. Gonzalez. N. Kassis, D. Damotte, L. Eloy, G. Fluteau, M. Levi-Strauss, and H. J. Garchon. 2001. Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice. Diabetes 50:2874.
39. Grattan, M., Q. S. Mi, C. Meagher, and T. L. Delovitch. 2002 Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51:215.
40. Boulard, O., D. Damotte, N. Deruytter, G. Fluteau, C. Camaud, and H. J. Garchon. 2002. An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd 16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. Diabetes 51:2141.
41. Brodnicki, T. C., F. Quirk. and G. Morahan. 2003. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes 52:218.
42. 2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc. Natl. Acad. Sci. USA 98:11533.
43. Baxter, A. G., A. C. Horsfall, D. Healey, P. Ozegbe, S. Day, D. G. Williams, and A. Cooke. 1994. Mycobacteria precipitate an SLE-like syndrome in diabetesprone NOD mice. Immunology 83:227.
44. Baxter, A. G., and A. Cooke. 1994. Peptide therapy for diabetes. Lancet 343:1169.
45. Baxter, A. G., D. Healey, and A. Cooke. 1994. Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity. Scand. J. Immunol. 39:602.
46. Horsfall, A. C., R. Howson, P. Silveira, D. G. Williams, and A. G. Baxter. 1998. Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice. Immunology 95:8.
47. Hawke, C. G., D. M. Painter, P. D. Kirwan, R. R. van Driel, and A. G. Baxter. 2003. Mycobacteria, an environmental enhancer of lupus nephritis in a mouse model of systemic lupus erythematosus. Immunology 108:70.
48. Silveira, P. A., and A. G. Baxter. 2001. The NOD mouse as a model of SLE. Autoimmunity 34:53.
49. Morel, L., C. Mohan, Y. Yu, B. P. Croker, N. Tian, A. Deng, and E. K. Wakeland. 1997. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158:6019.
50. 1 mice. Proc. Natl. Acad. Sci. USA 91:4062.
51. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91:10168.
52. Moser, K. L., B. R. Neas, J. E. Salmon, H. Yu, C. Gray-McGuire, N. Asundi, G. R. Bruner, J. Fox, J. Kelly, S. Henshall, et al. 1998. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. USA 95:14869.
53. Gaffney, P. M., G. M. Kearns, K. B. Shark, W. A. Ortmann, S. A. Selby, M. L. Malmgren, K. E. Rohlf, T. C. Ockenden, R. P. Messner, R. A. King, et al. 1998. A genome-wide search for susceptibility genes in human systemic lupus erytbematosus sib-pair families. Proc. Natl. Acad. Sci. USA 95:14875.
54. Ji, H., D. Gauguier, K. Ohmura, A. Gonzalez, V. Duchatelle, P. Danoy, H. J. Garchon, C. Degott, M, Lathrop, C. Benoist, and D. Mathis. 2001. Genetic influences on the end-stage effector phase of arthritis. J. Exp. Med. 194:321.
55. Johansson, A. C., M. Sundler, P. Kjellen, M. Johannesson, A. Cook, A. K. Lindqvist, B. Nakken, A. I. Bolstad, R. Jonsson, M. Alarcon-Riquelme, and R. Holmdahl. 2001. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 miee is dependent on gene regions encoding complement factor 5 and FcγRIIb and is not associated with loci controlling diabetes. Eur. J. Immunol. 31:1847.
56. Camaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647.
57. Eberl, G., and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985.
58. +NKT cells to the liver. J. Immunol. 165:1729.
59. Smyth, M. J., N. Y. Crowe. and D. I. Godfrey. 2001. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13:459.
60. Hayakawa, Y., K. Takeda, H. Yagita, S. Kakuta, Y. Iwakura, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31:1720.
61. Metelitsa, L. S., O. V. Naidenko, A. Kant, H. W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger. 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CDld with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167:3114.
62. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99:1259.
63. + NK T cells activated by α -galaetosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 168:3140.